Nuno Vau

1.0k total citations · 1 hit paper
13 papers, 267 citations indexed

About

Nuno Vau is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Nuno Vau has authored 13 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Nuno Vau's work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urologic and reproductive health conditions (4 papers). Nuno Vau is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urologic and reproductive health conditions (4 papers). Nuno Vau collaborates with scholars based in Portugal, Spain and Italy. Nuno Vau's co-authors include Liang Cheng, Rodolfo Montironi, Ana Blanca, Francesco Massari, Marina Scarpelli, Alessia Cimadamore, Antonio López-Beltrán, Jorge Fonseca, Maria Rosaria Raspollini and Giampaolo Tortora and has published in prestigious journals such as Human Pathology, Cancers and Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.

In The Last Decade

Nuno Vau

12 papers receiving 264 citations

Hit Papers

Immune Checkpoint Inhibitors for the Treatment of Bladder... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nuno Vau Portugal 7 163 128 93 79 43 13 267
Gopa Iyer United States 9 149 0.9× 103 0.8× 112 1.2× 47 0.6× 34 0.8× 52 299
Nick van Dijk Netherlands 8 151 0.9× 180 1.4× 52 0.6× 72 0.9× 65 1.5× 16 273
Victoria Hinder New Zealand 7 136 0.8× 109 0.9× 67 0.7× 64 0.8× 42 1.0× 18 264
Emily A. Egusa United States 5 132 0.8× 89 0.7× 62 0.7× 39 0.5× 28 0.7× 8 215
Alicia Teijeira Spain 3 92 0.6× 57 0.4× 119 1.3× 47 0.6× 65 1.5× 3 226
Jordan Kardos United States 7 129 0.8× 80 0.6× 111 1.2× 78 1.0× 28 0.7× 11 254
Florestan Koll Germany 9 97 0.6× 80 0.6× 44 0.5× 87 1.1× 27 0.6× 38 214
Scott J. Dawsey United States 5 100 0.6× 115 0.9× 103 1.1× 99 1.3× 11 0.3× 15 268
Thiru Prasanna Australia 10 88 0.5× 198 1.5× 99 1.1× 71 0.9× 65 1.5× 17 322
Carmen Mir Spain 7 121 0.7× 70 0.5× 93 1.0× 107 1.4× 23 0.5× 13 264

Countries citing papers authored by Nuno Vau

Since Specialization
Citations

This map shows the geographic impact of Nuno Vau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nuno Vau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nuno Vau more than expected).

Fields of papers citing papers by Nuno Vau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nuno Vau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nuno Vau. The network helps show where Nuno Vau may publish in the future.

Co-authorship network of co-authors of Nuno Vau

This figure shows the co-authorship network connecting the top 25 collaborators of Nuno Vau. A scholar is included among the top collaborators of Nuno Vau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nuno Vau. Nuno Vau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
López-Beltrán, Antonio, et al.. (2023). Pleomorphic giant cell carcinoma of the prostate: clinicopathologic analysis and oncological outcomes. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(3). 493–505. 6 indexed citations
2.
Monteiro, Fernando Sabino Marques, Ondřej Fiala, Francesco Massari, et al.. (2023). Systemic Immune-Inflammation Index in Patients Treated With First-Line Immune Combinations for Metastatic Renal Cell Carcinoma: Insights From the ARON-1 Study. Clinical Genitourinary Cancer. 22(2). 305–314.e3. 4 indexed citations
3.
López-Beltrán, Antonio, Ana Blanca, Fernando López‐Ríos, et al.. (2023). Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward. Expert Opinion on Biological Therapy. 23(5). 407–418. 7 indexed citations
4.
Raposo, Luís, et al.. (2022). A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents. Revista Portuguesa de Cardiologia. 41(12). 1047–1051. 2 indexed citations
5.
López-Beltrán, Antonio, Alessia Cimadamore, Ana Blanca, et al.. (2021). Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer. Cancers. 13(1). 131–131. 187 indexed citations breakdown →
6.
Santoni, Matteo, Francesco Massari, Sergio Bracarda, et al.. (2021). Body Mass Index in Patients Treated with Cabozantinib for Advanced Renal Cell Carcinoma: A New Prognostic Factor?. Diagnostics. 11(1). 138–138. 11 indexed citations
7.
Volavšek, Metka, Vanessa Henriques, Ana Blanca, et al.. (2019). Digital versus light microscopy assessment of extraprostatic extension in radical prostatectomy samples. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(6). 735–744. 3 indexed citations
8.
Vau, Nuno, Vanessa Henriques, Liang Cheng, et al.. (2019). Predicting biochemical recurrence after radical prostatectomy: the role of prognostic grade group and index tumor nodule. Human Pathology. 93. 6–15. 4 indexed citations
9.
Volavšek, Metka, Ana Blanca, Rodolfo Montironi, et al.. (2018). Digital versus light microscopy assessment of surgical margin status after radical prostatectomy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(3). 451–460. 7 indexed citations
10.
Ciccarese, Chiara, Francesco Massari, Ana Blanca, et al.. (2017). Tp53 and its potential therapeutic role as a target in bladder cancer. Expert Opinion on Therapeutic Targets. 21(4). 401–414. 29 indexed citations
11.
Vau, Nuno, Metka Volavšek, Ana Blanca, et al.. (2017). Prospects for precision therapy of bladder urothelial carcinoma. Expert Review of Precision Medicine and Drug Development. 2(5). 261–274. 1 indexed citations
12.
Massari, Francesco, Chiara Ciccarese, Nuno Vau, et al.. (2016). Emerging Immunotargets in Bladder Cancer. Current Drug Targets. 17(7). 757–770. 6 indexed citations
13.
Vau, Nuno, et al.. (2002). [Diagnosis of illiteracy in patients hospitalized at a nursing service. Prospective study].. PubMed. 14(3). 317–21.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026